Where does Medivators Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medivators Inc. ranks #5,528 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medivators Inc. hold?

Medivators Inc. holds 62 US utility patents granted between 2015 and 2025, spanning 25 technology areas.

What is Medivators Inc.'s Innovation Score?

Medivators Inc. has an Innovation Score of 51.9 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medivators Inc. focus on?

Medivators Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 39 patents, ranking #491 of 7,127 assignees active in that subclass. Grants appear in 25 CPC subclasses total.

Is Medivators Inc.'s patent grant rate increasing or decreasing?

Medivators Inc.'s recent grant velocity is -11% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Medivators Inc.'s patents?

Medivators Inc.'s patents average 15.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medivators Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Medivators Inc.

USPTO PatentsView assignee record - 62 granted patents across 25 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medivators ranks #5,528 of 49,997 tracked US assignees by granted-patent volume, with 62 patents across 25 technology areas.

#5,528
of 49,997 US assignees by volume: Top 11%
by Innovation Score (51.9/100): 15.5
avg claims per patent: -11%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5528 · US Corporation #5,528 · 62 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 62 grants
UPPER-Q #5,528/49,997
PHOTO-FINISH International Aids…
CPC-FOCUS A61B · 25 areas
INNOV-PAR 51.9/100
CLAIMS-RICH 15.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -11% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: International Aids Vaccine Initiative, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medivators’s 51.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.3 pts (28%) Velocity 10.6 pts (20%) Breadth 17.7 pts (34%) Claim depth 9.3 pts (18%)

Qualcomm Incorporated · highest

85
Advanced Liquid Logic · near

52
Harnischfeger · near

52
Inje University… · near

52
Medivators · this assignee

52
The Institute of… · near

52
3D Lighting… · lowest

7

What this shows Medivators's Innovation Score is 51.9/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medivators?

Each dot is one of Medivators’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medivators’s own 15.5 claims/patent is ABOVE the 10.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medivators vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medivators's grants concentrate

Medivators Inc. is a focused PatentsView assignee: 25 CPC subclasses with 62.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (8 grants) versus a trough of 2 in 2018. By volume, Medivators sits between International Aids Vaccine Initiative, Inc. and Nippon Suisan Kaisha, Ltd.

Medivators's three-year grant acceleration

Medivators Inc. shows 19 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

International Aid…

62
Kayaba Industry

62
Korea Kumho Petro…

62
Mitsubishi Paper…

62
Microsemi Soc

62
Muffin Incorporat…

62
Ningbo Semiconduc…

62
Nippon Suisan Kai…

62
Medivators ◀

62

What this shows Medivators holds 62 patents at rank #5,527, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medivators

By rank, the assignees closest to #5,527 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medivators's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medivators, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Medivators ranks #491 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (52 here).

Advanced Liquid Logic, Inc. 52 Inje University Industry-academic Cooperation Foundation 52 Harnischfeger Technologies, Inc. 52 The Institute of Cancer Research: Royal Cancer Hospital 52

Similar claim depth

Nearest assignees by average claims per patent (15.5 here).

Ultralogic 6G, LLC 15.5 avg Arconic Corporation 15.5 avg TEL Hashomer Medical Research Infrastructure AND Services Ltd. 15.5 avg Hefei BOE Display Technology Co., Ltd. 15.5 avg

Medivators's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medivators Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	4.8%
2016	7	11.3%
2017	8	12.9%
2018	2	3.2%
2019	7	11.3%
2020	2	3.2%
2021	3	4.8%
2022	6	9.7%
2023	6	9.7%
2024	7	11.3%
2025partial year	11	17.7%

Which technologies does Medivators Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 39

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 21

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 12

G06F - Electric Digital Data Processing 8

B08B - Cleaning IN GENERAL; Prevention OF Fouling IN General 8

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 7

Y10T - Technical Subjects Covered BY Former US Classification 5

D06M - Treatment, NOT Provided FOR Elsewhere IN Class D06, OF Fibres, Threads, Yarns, Fabrics, Feathers OR Fibrous Goods Made From Such Materials 5

G06V - Image OR Video Recognition OR Understanding 5

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

H04N - Pictorial Communication, e.g. Television 3

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 3

Top 15 of 25 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medivators Inc.'s patent record in context - here's where to go next.

Medivators Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 62.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #5,528 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medivators Inc. against International Aids Vaccine Initiative, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.